fa
1 augustus 2018

Two Joint publications on our 3D microfluidic platforms

1 augustus 2018

ciPTEC maintains its functionality in 3D fluidic cultures and secretes a proximal tubule specific miRNA pattern upon toxicant exposures. This work demonstrates the feasibility of ciPTEC to be used in 3D drug screenings.

Read more
1 september 2018

AstraZeneca demonstrates high specificity for ciPTEC-OAT1

1 september 2018

Using a validation set of 62 drugs, we developed a model that integrates multi-parametric data and drug exposure information, resulting in a sensitivity of 75% and a specificity of 100%. The assay is compatible with the requirements for early drug discovery screening and mitigation of the risk for nephrotoxicity.

Read more